Greystone Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-85,636
Closed -$6.71M 116
2023
Q3
$6.71M Sell
85,636
-12,676
-13% -$1.06M 1.67% 23
2023
Q2
$8.66M Buy
98,312
+8,370
+9% +$721K 2.01% 15
2023
Q1
$7.25M Buy
89,942
+377
+0.4% +$30.7K 1.83% 26
2022
Q4
$6.96M Buy
89,565
+1,413
+2% +$115K 2.05% 32
2022
Q3
$7.12M Buy
88,152
+3,400
+4% +$306K 2.41% 20
2022
Q2
$7.61M Buy
+84,752
New +$8.59M 2.37% 22

Other funds holding MDT

Greystone Financial Group's MDT Position: Q4 2023 in Review

Greystone Financial Group sold out of Medtronic (MDT) in Q4 2023, closing a stake of 85,636 shares — an estimated $6.71M sold.

Greystone Financial Group first reported a position in MDT in Q2 2022 and held it in 6 quarters. The position peaked at $8.66M in Q2 2023. 2,078 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Greystone Financial Group reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Greystone Financial Group sold 85,636 Medtronic shares in Q4 2023, an estimated $6.71M.
  • Greystone Financial Group first reported a position in Medtronic in Q2 2022 and held it in 6 quarters.
  • Greystone Financial Group's Medtronic position peaked at $8.66M in Q2 2023.
  • 2,078 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Greystone Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.